Cambridge Cognition Holdings plc Changes to the board

Cambridge Cognition Holdings plc (LON:COG), which develops and markets neuroscience technology to assess brain health, announces a number of changes to the Board of Directors which will take effect following the Annual General Meeting (“AGM”) scheduled for 23 May 2019, subject to approval of shareholders.

Steven Powell, Chief Executive Officer, commented:

“Mike Lewis and Nick Kerton were both appointed as Directors of the Company on 12 April 2013 as the Company listed on AIM. Mike has been Chairman of the Board since 8 May 2014 and Nick was Chief Executive Officer from September 2013 until the end of 2015. Both Mike and Nick retire from the company with our thanks for their service over the past six years.

“Matthew and I have had the benefit of working together for the past few months and Matthew inherits an exciting and innovative business which has made good progress in penetrating its core cognitive assessment and digital health markets. Matthew’s experience in healthcare and pharmaceuticals will bring a fresh commercial perspective to the business and we will be working together to accelerate the growth of the business.”

Both Michael Lewis and Nicholas Kerton who will retire by rotation at the forthcoming AGM will not offer themselves for re-election.

Steven Powell will retire by rotation at the forthcoming AGM and offer himself for re-election. Immediately following the AGM he will step down as Chief Executive Officer but continue as a Non-Executive Director and will take over as Chairman of the Board of Directors. In addition to his Chairman duties he will continue to play a significant role in key long-term corporate and R&D strategies.

Matthew Stork, the Company’s recently appointed Chief Operating Officer, will join the Board as Chief Executive Officer. He has expertise in a broad range of healthcare sectors including healthcare IT (including AI), diagnostic imaging, clinical service delivery and pharmaceuticals. He has held executive roles at the InHealth Group, General Electric, ArjoHuntleigh, Toshiba Medical Systems and Smith & Nephew.

The Company will seek to appoint an additional independent Non-Executive Director within the next three months.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition plc investor live webinar today

The interim results for the six months ended 30 June 2022 were released earlier today on 20 September 2022. The Company will conduct a live presentation and Q&A session for investors later today at 5:30 pm BST. The presentation

Cambridge Cognition Holdings

Cambridge Cognition growth in revenue of 31%

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced its unaudited interim results for the six months ended 30 June 2022. The Company followed its strong performance in 2021 with a 31%

Cambridge Cognition Holdings

Cambridge Cognition partnering with the University of Oxford

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it will be collaborating with the University of Oxford by providing cognitive assessments for the Impact of Semaglutide in Amyloid

Cambridge Cognition Holdings

Cambridge Cognition signs two PTSD trial agreements

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced two agreements in a new therapeutic area for the Company, post-traumatic stress disorder.  Most recently, a research agreement was entered into

Cambridge Cognition Holdings

Cambridge Cognition directors buy shares in company

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, announced today that it was informed on the 21st July 2022 of the following purchases of the Company’s ordinary shares by Directors and PDMRs of the

Cambridge Cognition Holdings

Cambridge Cognition to announce preliminary results on 12 April 2022

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, will announce its preliminary results for the year ended 31 December 2021 on 12 April 2022. Cambridge Cognition is a technology company developing digital

No more posts to show